Is BioXcel Therapeutics, Inc. (BTAI) a Buy, Sell, or Hold?
NASDAQ : BTAI
BioXcel Therapeutics, Inc. — Competitors
$0.9495 USD
$0.05 (5.3%)
- Volume
- 303.96K
- Average Volume
- 923.25K
- Market Capitalization
- $29.32M
- P/E Ratio
- -0.14
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $8.08
- Year Low
- $0.74
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.62
BTAI vs. The Competition
| Properties | BTAI | ANVS | BCAB | CELU |
|---|---|---|---|---|
| Market Cap | $29.32M | $36.59M | $5.94M | $21.07M |
| Shares Outstanding | $30.88M | $19.67M | $1.66M | $28.95M |
| P/E Ratio | -0.14 | -1.08 | -0.09 | -0.2 |
| EPS | -6.17 | -1.47 | -33.71 | -3.58 |
| Day Low | 0.893 | 1.86 | 3.37 | 0.68 |
| Day High | 0.9579 | 1.89 | 3.6299 | 0.735 |
| Year Low | 0.737 | 1.54 | 3.12 | 0.56 |
| Year High | 8.08 | 5.5 | 71.5 | 4.31 |
| Average Price 50 | 1.0505 | 1.8028 | 3.6585 | 0.76152 |
| Average Price 200 | 1.47038 | 2.50195 | 15.13323 | 1.20941 |
| Volume | 303.96K | 111.61K | 60773.31 | 12760.96 |
| Average Volume | - | - | - | - |